Therapeutic Options in Ambulatory Advanced Heart Failure: A Moving Target

Shannon M Dunlay; Thomas C Hanff; Stavros G Drakos

doi:10.1016/j.jchf.2024.04.029

Therapeutic Options in Ambulatory Advanced Heart Failure: A Moving Target

JACC Heart Fail. 2024 Oct;12(10):1747-1749. doi: 10.1016/j.jchf.2024.04.029. Epub 2024 Jul 3.

Authors

Shannon M Dunlay¹, Thomas C Hanff², Stavros G Drakos³

Affiliations

¹ Department of Cardiovascular Medicine and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: [email protected].
² Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
³ Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA; Nora Eccles Harrison Cardiovascular Research and Training Institute, Salt Lake City, Utah, USA.

PMID: 38970590
PMCID: PMC11464207 (available on 2025-10-01)
DOI: 10.1016/j.jchf.2024.04.029

No abstract available

Keywords: advanced heart failure; functional capacity; guideline-directed medical therapy; health-related quality of life; patient-reported outcomes; survival; ventricular assist device.

Publication types

Editorial

MeSH terms

Ambulatory Care / methods
Heart Failure* / drug therapy
Heart Failure* / therapy
Humans

Grants and funding

L30 HL170339/HL/NHLBI NIH HHS/United States